Target intelligence / Profile preview

Novel protein, readthrough between SLC5A3 and MRPS6

Molecular classification: Readthrough transcript, Chimeric gene product, Novel protein

Overview

This target refers to a readthrough transcript (ENSG00000293606) that spans two known protein-coding genes: SLC5A3 and MRPS6. There is no evidence this readthrough gene produces a well-characterized, independent protein, nor does it function as a canonical therapeutic target. Consequently, no standardized full name or widely accepted abbreviation exists for this specific readthrough product. Its database description is 'Novel Protein, Readthrough Between SLC5A3 and MRPS6'.

Other names: ENSG00000293606SLC5A3-MRPS6 readthrough

Beyond the preview

Go deeper on Novel protein, readthrough between SLC5A3 and MRPS6.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Novel protein, readthrough between SLC5A3 and MRPS6.

Explore the full profile